SCHEMBL10363602

SCHEMBL10363602

CCCCC(=O)Cc1cc(-n2ccnc2)cs1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.41
CYP2D6 P10635 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP19A1 P11511 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
TBXAS1 P24557 2/20 0.39
BAZ2B Q9UIF8 1/20 0.38
HTT P42858 1/20 0.36
KDM4E B2RXH2 1/20 0.36
MEN1 O00255 1/20 0.36
MITF O75030 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
MAPK8 P45983 1/20 0.35
MAPK10 P53779 1/20 0.35
GLS O94925 2/20 0.34
ADH5 P11766 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10365503 0.93 CYP3A4 (0.40) CYP3A4CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL10364581 0.87 CYP3A4 (0.41) CYP3A4CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL10365545 0.82 CYP3A4 (0.47) CYP3A4TBXAS1BAZ2BHTTKDM4E
SCHEMBL10759770 0.77 TBXAS1 (0.58) CYP3A4CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL10364635 0.77 CYP3A4 (0.39) CYP3A4CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL8828396 0.73 CYP3A4 (0.38) CYP3A4CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL10761593 0.69 TBXAS1 (0.57) CYP3A4CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL10363622 0.68 CYP3A4 (0.38) CYP3A4CYP2D6CYP1A2CYP19A1CYP2C9
SCHEMBL10651014 0.67 TBXAS1 (0.48) CYP3A4TBXAS1BAZ2BHTTADH5
SCHEMBL14307267 0.66 CYP3A4 (0.46) CYP3A4CYP2D6CYP1A2CYP19A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0175187-B1 3,4-DIHYDRO-2(1H)-PYRIDONES AND 2(1H)-PYRIDONES CONTAINING IMIDAZOLE GROUPS, METHOD FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM A. Nattermann & Cie. GmbH (DE) 1990-01-10 EP disclosed
US-4699914-A CONGESTIVE HEART FAILURE A. NATTERMANN & CIE GMBH (DE) 1987-10-13 US disclosed
EP-0175187-A1 3,4-Dihydro-2(1H)-pyridones and 2(1H)-pyridones containing imidazole groups, method for their preparation and medicaments containing them A. Nattermann & Cie. GmbH (DE) 1986-03-26 EP disclosed